Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials

Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials

Abstract Background The humanized monoclonal antibody galcanezumab is an anti-calcitonin-gene-related-peptide (CGRP) and frequently used for migraine prevention. However, the literature revealed limited data with conflicting results. This study aims to assess the safety and efficacy of galcanezumab...

Full description

Bibliographic Details
Main Authors: Mohamed Sayed Zaazouee, Rokaya Y. Ebrahim, Ghaida’a Al-araj, Ibram Zaki, Ahmed Saad, Abdullah Mohamed Farhat, Mustafa Hussein Ali, Mohamed Elshennawy, Omar Khaled Fahmy Fawy, Hadi F. Ahmed, Ziad Alahmad, Eman Ayman Nada, Reem I. Abo-Hamra, Ahmed Bostamy Elsnhory, Mohammed Eleyan, Hazem AbuEl-Enien, Rasha Abdo Elromely, Yossef Hassan AbdelQadir, Jaffer Shah, Alaa Ahmed Elshanbary
Format: Article
Language:English
Published: SpringerOpen 2024-05-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
Galcanezumab
LY2951742
Migraine
Headache
Meta-analysis
Online Access:https://doi.org/10.1186/s41983-024-00834-8

Internet

https://doi.org/10.1186/s41983-024-00834-8

Similar Items